GAMP 5: How to Apply Risk-Based Validation in the Pharmaceutical Industry.
When a pharmaceutical company implements a new LIMS, MES, ERP module, electronic document management system or cloud application, one question
When a pharmaceutical company implements a new LIMS, MES, ERP module, electronic document management system or cloud application, one question
1. Introduction Commissioning, Qualification and Validation (CQV) is a critical component of pharmaceutical facility and manufacturing-system lifecycle management. A well-designed
Modern pharmaceutical equipment increasingly depends on computerized and automated functions for process control, monitoring, alarms, recipes, electronic records, data acquisition,
Part 19 Initial qualification demonstrates that a facility, utility, equipment, or system is suitable for its defined intended use at
Requalification is the documented evaluation and, where justified, repeat verification of a previously qualified facility, utility, equipment, or system to
Part 17 Change control is one of the principal mechanisms for maintaining the qualified state after a facility, utility, equipment,
Part 16 The Qualification Summary Report (QSR) is the principal lifecycle-closure document used to consolidate, assess, and conclude whether qualification
Part 15 Deviation management is a critical component of qualification because qualification testing is specifically intended to determine whether a
Part 13 The protocol converts the qualification strategy into executable evidence: Requirement → Risk → Test Objective → Test Method
Part 12 URS → Risk Assessment → Design → FAT/SAT → IQ → OQ → PQ → SOP/Control → Final